JPS626697B2 - - Google Patents

Info

Publication number
JPS626697B2
JPS626697B2 JP2863880A JP2863880A JPS626697B2 JP S626697 B2 JPS626697 B2 JP S626697B2 JP 2863880 A JP2863880 A JP 2863880A JP 2863880 A JP2863880 A JP 2863880A JP S626697 B2 JPS626697 B2 JP S626697B2
Authority
JP
Japan
Prior art keywords
general formula
represented
formula
cyclohexen
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2863880A
Other languages
Japanese (ja)
Other versions
JPS56123937A (en
Inventor
Yasumitsu Tamura
Masao Murayama
Shingo Matsumura
Yoshihiko Yoshimoto
Shinichi Tanda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP2863880A priority Critical patent/JPS56123937A/en
Publication of JPS56123937A publication Critical patent/JPS56123937A/en
Publication of JPS626697B2 publication Critical patent/JPS626697B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は次の一般式〔〕で表わされる4―オ
キソ―2―(4―置換フエニル)―2―シクロヘ
キセン―1―イル酢酸の製造法に関する。 ただしR1は水素又はハロゲンを表わす。 一般式〔〕で表わされる化合物のうちR1
水素の化合物は文献既知(J.Chem.Soc.Perkin
,1973,1451)であるがR1が塩素の化合物は
文献未知である。 本発明で製造される化合物は、例えばこれを低
級アルキルエステルとなした後ヨード化剤と反応
させて化合物〔〕となし、これを例えばカセイ
アルカリで加水分解することにより容易に化合物
〔〕に導くことができる。 ただしR1は前記と同じ、R2は低級アルキルを
表わす。 化合物〔〕はすぐれた抗炎症作用、鎮痛作
用、血小板擬集抑制作用を有し、医薬品として有
用である。よつて本発明で製造される化合物は、
医薬品合成中間体として有用である。 一般式〔〕の化合物のうち、R1が塩素の化
合物については、文献記載(J.Chem.Soc.Perkin
,1973,1451)の反応条件を準用して製造する
ことができなかつた。従来一般式〔〕において
R1が水素である化合物は3―(ベンゾイル)プ
ロピオン酸を出発原料として下に示す経路で製造
されており、反応式からわかる様に、マンニツヒ
塩基の形成、メチルエステルの製造、環化からな
つている。しかしR1が塩素である化合物の製造
においては、第一段階のマンニツヒ塩基の形成が
全く進行せず、このことから公知の方法の幅広い
応用性には擬問が持たれる。 本発明者らは更に簡便で一般的に応用し得る製
造法の確立を目的として種々研究を重ねた結果、
一般式〔〕で表わされる3―(4―置換ベンゾ
イル)プロピオン酸エステルを塩基の存在下でメ
チルビニルケトンと反応させると一段階で一般式
〔〕で表わされる化合物が生成するという簡便
な方法を確立し、本発明を完成したのである。 ただしR1,R2は前記と同じ。 本発明で使用される塩基は通常の有機合成反応
で繁用されるものでよいが、好ましくは、カリウ
ム第3級プトオキシド、DBUを用いるのがよ
く、又、溶媒は不活性溶媒、好ましくは、トルエ
ン、第3級ブタノールがよい。好適な反応温度は
0℃〜110℃である。本発明の生成物である一般
式〔〕で表わされる2―(4―置換フエニル)
―2―シクロヘキセン―1―イル酢酸は通常の分
離法を用い容易に分離できる。この方法によつて
既知の化合物である一般式〔〕で表わされる化
合物のうちR1が水素のものも文献既知の方法に
比較し、格段に簡便に製造できる。従つて本発明
の方法は一般式〔〕で表わされる化合物の最も
簡便な製造法といえる。次に実施例を掲げ本発明
を一層明らかにする。 実施例 1 3―(4―クロロベンゾイル)プロピオン酸エ
チル28.8gとメチルビニルケトン15gを第3級ブ
タノール120mlに溶解し、別に金属カリウム5g
と第3級ブタノール100mlから調製した溶液の1/1
0量を氷冷下にゆつくり滴下し室温にて一夜放置
したのち、反応液を撹拌還流下に更に9/10量を滴
下し3時間反応させる。放冷後減圧下に第3級ブ
タノールを溜去し、残渣に10%塩酸を加えて酸性
にする。ベンゼンで抽出し、ベンゼン溶液を炭酸
水素ナトリウム水溶液で抽出する。抽出液を酸性
とし析出結晶をメタノールから再結晶して4―オ
キソ―2―(4―クロロフエニル)―2―シクロ
ヘキセン―1―イル酢酸14.1g、収率41%、融点
176〜178℃を得る。 元素分析値 C14H18ClO3として 計算値 C:63.52、H:4.95、Cl:13.39 実験値 C:63.70、H:5.02、Cl:13.27 赤外線吸収スペクトル(KBr法)3200〜2600(微
細吸収)1728(−COOH)、1635(C=C)1607
The present invention relates to a method for producing 4-oxo-2-(4-substituted phenyl)-2-cyclohexen-1-yl acetic acid represented by the following general formula []. However, R 1 represents hydrogen or halogen. Among the compounds represented by the general formula [], compounds in which R 1 is hydrogen are known from the literature (J.Chem.Soc.Perkin
, 1973, 1451), but compounds in which R 1 is chlorine are unknown in the literature. The compound produced in the present invention is, for example, converted into a lower alkyl ester and then reacted with an iodinating agent to form the compound [], which can be easily led to the compound [] by hydrolyzing it with, for example, caustic alkali. be able to. However, R 1 is the same as above, and R 2 represents lower alkyl. Compound [] has excellent anti-inflammatory effect, analgesic effect, and platelet aggregation inhibitory effect, and is useful as a pharmaceutical. Therefore, the compound produced by the present invention is
It is useful as an intermediate in pharmaceutical synthesis. Among the compounds of the general formula [], compounds in which R 1 is chlorine are described in the literature (J.Chem.Soc.Perkin
, 1973, 1451). In the conventional general formula []
Compounds in which R 1 is hydrogen are produced using 3-(benzoyl)propionic acid as a starting material by the route shown below. ing. However, in the production of compounds in which R 1 is chlorine, the formation of the Mannitz base in the first step does not proceed at all, which casts doubt on the wide applicability of the known method. As a result of various research aimed at establishing a simpler and generally applicable manufacturing method, the present inventors found that
A simple method in which the compound represented by the general formula [] is produced in one step by reacting 3-(4-substituted benzoyl)propionic acid ester represented by the general formula [] with methyl vinyl ketone in the presence of a base. They established this and completed the present invention. However, R 1 and R 2 are the same as above. The base used in the present invention may be one frequently used in ordinary organic synthesis reactions, but potassium tertiary nitoxide, DBU is preferably used, and the solvent is an inert solvent, preferably, Toluene and tertiary butanol are preferable. The preferred reaction temperature is 0°C to 110°C. 2-(4-substituted phenyl) represented by the general formula [] which is a product of the present invention
-2-Cyclohexen-1-yl acetic acid can be easily separated using conventional separation methods. By this method, known compounds represented by the general formula [], in which R 1 is hydrogen, can be produced much more easily than with methods known in the literature. Therefore, the method of the present invention can be said to be the simplest method for producing the compound represented by the general formula []. Next, examples will be given to further clarify the present invention. Example 1 28.8 g of ethyl 3-(4-chlorobenzoyl)propionate and 15 g of methyl vinyl ketone were dissolved in 120 ml of tertiary butanol, and separately 5 g of metallic potassium was dissolved.
and 1/1 of the solution prepared from 100 ml of tertiary butanol.
0 amount was slowly added dropwise under ice-cooling and allowed to stand overnight at room temperature, and then an additional 9/10 amount was added dropwise to the reaction solution while stirring and refluxing, and the mixture was allowed to react for 3 hours. After cooling, tertiary butanol is distilled off under reduced pressure, and 10% hydrochloric acid is added to the residue to make it acidic. Extract with benzene and extract the benzene solution with aqueous sodium bicarbonate solution. The extract was acidified and the precipitated crystals were recrystallized from methanol to give 14.1 g of 4-oxo-2-(4-chlorophenyl)-2-cyclohexen-1-yl acetic acid, yield 41%, melting point.
Obtain 176-178°C. Elemental analysis value C 14 H 18 ClO 3 Calculated value C: 63.52, H: 4.95, Cl: 13.39 Experimental value C: 63.70, H: 5.02, Cl: 13.27 Infrared absorption spectrum (KBr method) 3200-2600 (fine absorption) 1728 (-COOH), 1635 (C=C) 1607

【式】827cm-1核磁気吸収スペクトル (CDCl3)、δ、2.2〜2.7(6H、m、
[Formula] 827cm -1 nuclear magnetic absorption spectrum (CDCl 3 ), δ, 2.2-2.7 (6H, m,

【式】及び[Formula] and

【式】)3.3〜3.7 (1H、m、[Formula]) 3.3 to 3.7 (1H, m,

【式】)6.33(1H、s、[Formula]) 6.33 (1H, s,

【式】)7.44(4H、s、[Formula]) 7.44 (4H, s,

【式】)7.8〜8.2(1H、−COOH、 D2O添加によつて消失する)マススペクトル:
m/e 264(M+、ベースピーク)219(M+
COOH)、204
[Formula]) 7.8-8.2 (1H, -COOH, disappears upon addition of D2O ) Mass spectrum:
m/e 264 (M + , base peak) 219 (M +
COOH), 204

【式】 実施例 2 3―(4―クロロベンゾイル)プロピオン酸エ
チル2.4gとメチルビニルケトン1.4gを乾燥トル
エン10mlに溶解しDBU1.6gを加えて室温にて2
時間撹拌したのち、更に2時間還流撹拌する。溶
媒を溜去し、残渣を実施例1の後処理法に準じて
処理し、4―オキソ―2―(4―クロロフエニ
ル)―2―シクロヘキセン―1―イル酢酸1.4
g、収率45%を得る。これは実施例1で得られた
ものと融点、スペクトルデーターが完全に一致す
る。 同様の方法で既知の4―オキソ―2―フエニル
―2―シクロヘキセン―1―イル酢酸、融点139
〜142℃(文献値136〜137℃)〔2,4―ジニトロ
フエニルヒドラゾン融点232〜233℃(文献値232
℃)〕が製造できる。
[Formula] Example 2 2.4 g of ethyl 3-(4-chlorobenzoyl)propionate and 1.4 g of methyl vinyl ketone were dissolved in 10 ml of dry toluene, 1.6 g of DBU was added, and 2.
After stirring for an hour, the mixture was further stirred under reflux for 2 hours. The solvent was distilled off, and the residue was treated according to the post-treatment method of Example 1 to give 1.4% of 4-oxo-2-(4-chlorophenyl)-2-cyclohexen-1-yl acetic acid.
g, yield 45%. This completely matches the melting point and spectrum data obtained in Example 1. 4-oxo-2-phenyl-2-cyclohexen-1-yl acetic acid, melting point 139, known in a similar manner.
~142℃ (Literature value 136-137℃) [2,4-dinitrophenylhydrazone melting point 232-233℃ (Literature value 232
℃)] can be produced.

Claims (1)

【特許請求の範囲】 1 次の一般式〔〕 で表わされる3―(4―置換ベンゾイル)プロピ
オン酸エステルを、塩基の存在下でメチルビニル
ケトンと反応させることを特徴とする次の一般式
〔〕 で表わされる4―オキソ―2―(4―置換フエニ
ル)―2―シクロヘキセン―1―イル酢酸の製造
法。 ただしR1は水素又はハロゲンを表わし、R2
低級アルキルを表わす。
[Claims] First-order general formula [] The following general formula [] is characterized by reacting a 3-(4-substituted benzoyl)propionic acid ester represented by with methyl vinyl ketone in the presence of a base. A method for producing 4-oxo-2-(4-substituted phenyl)-2-cyclohexen-1-yl acetic acid represented by However, R 1 represents hydrogen or halogen, and R 2 represents lower alkyl.
JP2863880A 1980-03-06 1980-03-06 Preparation of cyclohexene derivative Granted JPS56123937A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2863880A JPS56123937A (en) 1980-03-06 1980-03-06 Preparation of cyclohexene derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2863880A JPS56123937A (en) 1980-03-06 1980-03-06 Preparation of cyclohexene derivative

Publications (2)

Publication Number Publication Date
JPS56123937A JPS56123937A (en) 1981-09-29
JPS626697B2 true JPS626697B2 (en) 1987-02-13

Family

ID=12254064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2863880A Granted JPS56123937A (en) 1980-03-06 1980-03-06 Preparation of cyclohexene derivative

Country Status (1)

Country Link
JP (1) JPS56123937A (en)

Also Published As

Publication number Publication date
JPS56123937A (en) 1981-09-29

Similar Documents

Publication Publication Date Title
JPH06199773A (en) Benzoic acid intermediate with three substituents
JPH032134B2 (en)
JPH01156965A (en) Thiohydantoin compound
JPS626697B2 (en)
US4009172A (en) 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones
JPH07215952A (en) Catechol derivative
JPS629098B2 (en)
JPH0466219B2 (en)
JPH05286902A (en) Production of alpha-chloro-beta-ketoester derivative
US4213905A (en) Preparation of 5-aroyl-1-loweralkylpyrrole-2-acetic acid salts
JP2527961B2 (en) Benzoic acid ester derivative and method for producing the same
JPH0378384B2 (en)
JPH053859B2 (en)
JPS584698B2 (en) Method for producing 2-(3-benzoylphenyl)propionic acid
WO2006123648A1 (en) Process for producing 3-substituted thiophene
JPS5837299B2 (en) 2- Nitrobenzaldehyde
JP4060718B2 (en) New production method of enol ether
JP2000344722A (en) Production of 4-hydroxymethyl-1-aminocyclopent-2-ene derivative
KR950013468B1 (en) Preparation of p-alkoxy-ñô-phenyl acrylic acid
JP2002512210A (en) Method for producing 2-hydroxyalkylhalophenone
JPS649987B2 (en)
JP3569877B2 (en) Method for producing m-substituted-α-hydroxymethylstyrene derivative and 3-chloro-α-bromostyrene
WO1993013060A1 (en) Novel intermediate compound and production thereof
JPH07252183A (en) Production of phenol derivative
JPS5857325A (en) P-(3,3,3-trifluoropropyl)benzyl derivative and its production